Saturday 17 October 2026
Export KRMD’s income statement to Excel — free account
KORU Medical Systems, Inc.
KRMD Healthcare Medical Instruments & Supplies
KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024. In the quarter to June 2026, revenue grew 18.2%, EPS grew 222.2%, free cash flow grew 26.2% and total debt fell 50.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
3.00
0.03
−0.99%
Follow KRMD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Feb '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 5 | 2 | 2 | 2 | 4 | 7 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 366.85 | 77.46 | 44.35 | 0.00 |
Altman Z-Score |
14.46 | 9.64 | 7.62 | 8.91 | 17.59 | 41.91 | 60.54 | 27.26 | 20.85 | 8.88 |
P/S ratio |
6.52 | 5.24 | 3.81 | 5.73 | 5.67 | 10.44 | 10.93 | 3.63 | 3.02 | 1.31 |
Altman Z″-Score (non-manufacturers) |
(0.06) | (0.54) | 1.18 | 4.08 | 11.95 | 15.74 | 10.36 | 12.64 | 11.57 | 9.41 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,244.86 | 62.62 | 58.94 | 0.00 |
Beneish M-Score |
(2.90) | (3.33) | (4.17) | (1.97) | (1.50) | (2.83) | (1.28) | (2.77) | (2.33) | — |
P/Operating CF |
245.11 | 187.68 | 98.95 | 119.53 | (185.69) | (147.47) | 307.83 | 496.15 | 99.73 | (40.76) |
P/B ratio |
15.74 | 10.49 | 5.33 | 5.10 | 3.65 | 6.98 | 22.54 | 7.02 | 5.24 | 2.43 |
Price to Tangible BV |
16.40 | 10.96 | 5.54 | 5.23 | 3.73 | 7.15 | 24.28 | 7.55 | 5.59 | 2.60 |
EV/Sales |
6.31 | 4.96 | 3.41 | 5.12 | 4.59 | 9.31 | 10.68 | 3.32 | 2.70 | 1.02 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 267.15 | 39.12 | 24.06 | 0.00 |
EV/Operating CF |
561.32 | (522.25) | (19.90) | (26.41) | (24.97) | (302.97) | 771.53 | 38.96 | 39.93 | (23.14) |
EV/FCF |
(532.53) | (101.02) | (17.06) | (17.39) | (23.02) | (126.56) | 2,192.84 | 57.39 | 52.72 | (12.27) |
Quick Ratio |
1.88 | 2.16 | 3.49 | 3.15 | 6.19 | 8.15 | 3.78 | 4.22 | 3.85 | 3.78 |
Current Ratio |
2.44 | 2.66 | 4.55 | 4.28 | 7.79 | 10.24 | 4.94 | 5.70 | 5.00 | 4.88 |
Net Debt/EBITDA |
4.07 | 1.69 | 1.19 | 1.67 | 3.86 | 34.27 | (6.34) | (3.57) | (2.84) | 8.77 |
Debt/Assets |
0.28% | 0.74% | 1.11% | 0.93% | 0.00% | 0.24% | 0.02% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.48 | 1.21 | 0.81 | 0.67 | 0.58 | 0.90 | 1.90 | 1.75 | 1.53 | 1.48 |
Operating CF/Net income |
(0.18) | 0.05 | 0.36 | 0.62 | 0.95 | 0.61 | 0.57 | 1.63 | 0.99 | 0.62 |
Capex/Depreciation |
(1.17) | (1.50) | (0.94) | (4.77) | (0.79) | (2.25) | (0.61) | (1.54) | (0.85) | (1.26) |
Interest Coverage |
— | — | — | (74.04) | (536.60) | (29.59) | 7.26 | 41.44 | 426.38 | (387.47) |
| (15.58%) | (32.64%) | (53.18%) | (25.54%) | (12.56%) | (5.12%) | 5.59% | 10.95% | 12.62% | (7.76%) | |
| (9.52%) | (21.79%) | (38.82%) | (20.71%) | (11.24%) | (4.51%) | 4.62% | 9.19% | 10.37% | (6.46%) | |
ROIC |
(22.51%) | (54.19%) | (69.86%) | (47.08%) | (39.35%) | (8.78%) | 6.82% | 19.65% | 22.52% | (14.84%) |
Return on Tangible Assets |
(16.22%) | (37.40%) | (69.97%) | (32.40%) | (13.57%) | (3.46%) | 5.59% | 10.96% | 12.60% | (8.46%) |
Average Days of Receivables |
57.95 | 65.07 | 52.14 | 59.29 | 66.99 | 38.85 | 50.97 | 29.99 | 51.04 | 49.72 |
Research and Development Expense of Revenue |
10.67% | 15.63% | 20.14% | 17.77% | 10.53% | 5.36% | 3.20% | 1.39% | 0.38% | 1.93% |
Selling, General and Administrative Expense of Revenue |
56.84% | 64.29% | 71.41% | 73.87% | 76.04% | 49.75% | 42.19% | 47.23% | 49.53% | 63.18% |
Intangible Assets out of Total Assets |
0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.06 | 0.06 | 0.05 | 0.05 |
Share Based Compensation of Revenue |
6.60% | 7.80% | 9.71% | 11.04% | 11.53% | 6.70% | 5.20% | 2.11% | 0.81% | 1.67% |
Graham Net Nets |
0.03 | 0.05 | 0.11 | 0.12 | 0.24 | 0.13 | 0.04 | 0.12 | 0.16 | 0.33 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.34 | 0.33 | 0.00 |
Earnings Yield |
(1.11%) | (3.12%) | (12.18%) | (5.63%) | (3.33%) | (0.57%) | 0.27% | 1.29% | 2.25% | (4.07%) |
Free Cash Flow Yield |
(0.18%) | (0.94%) | (5.26%) | (5.14%) | (3.52%) | (0.70%) | 0.04% | 1.60% | 1.70% | (6.36%) |
Revenue per Share |
0.89 | 0.73 | 0.63 | 0.62 | 0.53 | 0.58 | 0.60 | 0.46 | 0.35 | 0.33 |
Operating CF per Share |
0.01 | (0.01) | (0.11) | (0.12) | (0.10) | (0.02) | 0.01 | 0.04 | 0.02 | (0.01) |
Capex per Share |
(0.02) | (0.03) | (0.02) | (0.06) | (0.01) | (0.02) | (0.01) | (0.01) | (0.01) | (0.01) |
Free Cash Flow per Share |
(0.01) | (0.04) | (0.13) | (0.18) | (0.11) | (0.04) | 0.00 | 0.03 | 0.02 | (0.02) |
Cash per Share |
0.19 | 0.21 | 0.25 | 0.39 | 0.57 | 0.65 | 0.15 | 0.14 | 0.11 | 0.09 |
Shareholders Equity per Share |
0.37 | 0.37 | 0.45 | 0.70 | 0.82 | 0.86 | 0.29 | 0.24 | 0.20 | 0.18 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.37 | 0.37 | 0.45 | 0.70 | 0.82 | 0.86 | 0.29 | 0.24 | 0.20 | 0.18 |
Free Cash Flow |
(0.49) | (1.65) | (5.71) | (8.21) | (4.69) | (1.78) | 0.11 | 1.00 | 0.68 | (0.75) |
Working Capital |
11.79 | 11.93 | 15.80 | 22.84 | 32.53 | 33.86 | 9.48 | 7.45 | 6.34 | 5.39 |
Capital Expenditures |
(0.95) | (1.33) | (0.81) | (2.80) | (0.37) | (1.04) | (0.21) | (0.48) | (0.22) | (0.42) |
Net Current Asset Value |
8.84 | 8.73 | 12.15 | 18.80 | 32.53 | 33.76 | 9.24 | 7.45 | 6.32 | 5.29 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 422.25 | 49.51 | 29.06 | 0.00 |
Capex to Sales |
0.02 | 0.04 | 0.03 | 0.10 | 0.02 | 0.04 | 0.01 | 0.03 | 0.02 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 432.26 | 54.02 | 32.49 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.18 | 0.21 | 0.23 | 0.15 | 0.42 | 0.39 | 0.56 | 0.36 | 0.31 | 0.35 |
Cash ROIC |
(1.87%) | (6.21%) | (17.75%) | (16.70%) | (7.58%) | (2.80%) | 0.66% | 7.07% | 5.72% | (7.28%) |
Accounts Receivable Turnover |
6.57 | 6.68 | 6.63 | 6.31 | 6.82 | 8.33 | 9.94 | 10.56 | 7.53 | 8.13 |
Accounts Payable Turnover |
7.93 | 9.38 | 7.01 | 6.92 | 10.50 | 15.43 | 16.19 | 14.41 | 8.44 | 8.75 |
Inventory Turnover |
4.79 | 3.92 | 2.39 | 2.00 | 1.50 | 2.00 | 3.70 | 3.48 | 3.44 | 3.95 |
Average Days of Payables |
53.32 | 48.91 | 30.14 | 69.69 | 46.09 | 24.68 | 25.16 | 25.30 | 32.05 | 59.68 |
Days of Inventory on Hand |
86.48 | 83.10 | 107.60 | 186.62 | 229.29 | 269.78 | 104.93 | 117.36 | 116.99 | 104.59 |
Average Receivables |
6.26 | 5.04 | 4.30 | 4.42 | 3.44 | 2.90 | 2.33 | 1.64 | 1.77 | 1.51 |
Average Payables |
1.96 | 1.31 | 1.68 | 1.81 | 0.93 | 0.60 | 0.51 | 0.45 | 0.61 | 0.54 |
Average Inventory |
3.24 | 3.14 | 4.94 | 6.26 | 6.47 | 4.61 | 2.25 | 1.88 | 1.51 | 1.20 |
Average Assets |
27.71 | 27.84 | 35.40 | 41.81 | 40.61 | 26.90 | 12.21 | 9.91 | 8.73 | 8.28 |
Average Common Equity |
16.93 | 18.58 | 25.84 | 33.91 | 36.33 | 23.70 | 10.10 | 8.32 | 7.17 | 6.90 |
Columns are period end dates